Doxa AB
STO:DOXA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.01
3.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Doxa AB
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | SE |
Market Cap | 1.3B SEK |
Net Margin |
-1 239%
|
Country | JP |
Market Cap | 6.8T JPY |
Net Margin |
24%
|
Country | CH |
Market Cap | 37.9B CHF |
Net Margin |
12%
|
Country | DK |
Market Cap | 200.9B DKK |
Net Margin |
19%
|
Country | US |
Market Cap | 16.9B USD |
Net Margin |
11%
|
Country | KR |
Market Cap | 9.9T KRW |
Net Margin |
-358%
|
Country | CA |
Market Cap | 6.9B USD |
Net Margin |
-8%
|
Country | CN |
Market Cap | 48.6B CNY |
Net Margin |
42%
|
Country | US |
Market Cap | 6.3B USD |
Net Margin |
29%
|
Country | US |
Market Cap | 6.1B USD |
Net Margin |
9%
|
Country | UK |
Market Cap | 4.8B GBP |
Net Margin |
7%
|
Doxa AB
Glance View
Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-07. The firm develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Doxa AB's most recent financial statements, the company has Net Margin of -1 239.3%.